ow-energy extracorporeal cardiac shock wave therapy in patients with severe ischemic heart disease

Not Applicable

• Conditions: Angina pectoris

• Registration Number: JPRN-UMIN000011484
• Lead Sponsor: chibanishi general hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients whose target area cannot be observed with echocardiography. 2) Post-breast augmentation surgery with silicon pad. 3) Patients with prosthetic valve (mechanical valve) in the heart. 4) Q-wave myocardial infarction within 3 months. 5) Non-Q-wave myocardial infarction within 6 weeks. 6) Less than 1 month after the last revascularization (PCI or CABG). 7) Patients with cardiogenic shock or worsening heart failure (who require continuous infusion of cardiovascular agents such as inotropic agents or vasodilators). 8) Intracardiac thrombus. 9) Patients whose clinical status changed after the last coronary angiography. 10) Unstable diabetic retinopathy. 11) Patients who have malignancy or who have undergone surgery because of malignancy within the past five years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency in use of nitroglycerin per week. Evaluated at 3 month after the therapy.

Secondary Outcome Measures

Name	Time	Method
CCS class scores, Exercise tolerance, Myocardial perfusion. Evaluated at 3 month after the therapy.